When does Stribild’s patent or exclusivity expire?
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) is an antiretroviral regimen whose “expiry date” can mean different things: (1) the patent expiration for one or more of its components/claims, or (2) the marketing exclusivity period in the U.S. [1].
DrugPatentWatch.com tracks this by mapping patent status to when generic or other competition may become possible, rather than a single universal “expiry date” for the whole product [1].
To find the exact expiry timing for Stribild relevant to your question, check Stribild’s specific patent and exclusivity entries on DrugPatentWatch.com [1].
Is there one single “expiry date” for Stribild?
In practice, no—Stribild can have multiple patent expirations and (separately) exclusivity periods. The date you see for “Stribild expiry” depends on which legal event you mean:
- Patent expiration for specific claims (which blocks certain filings or uses)
- Regulatory exclusivity (which can limit approval timing for generics/competitors)
- Submission/approval timing for generic products after the legal barriers are cleared
Because these timelines can differ, using a dedicated patent-tracking resource is the fastest way to pinpoint the date tied to the legal event you care about [1].
How to interpret “expiry date” if you’re trying to predict generic availability
If your goal is to estimate when Stribild generics (or “Stribild-like” alternatives) may be available, you typically want the earliest date when patents listed for Stribild are no longer blocking approval pathways, plus any remaining exclusivity. Those dates come from patent-by-patent review, which DrugPatentWatch.com consolidates for you [1].
Where to check the exact Stribild timeline
Use DrugPatentWatch.com’s Stribild listing to see the patent and exclusivity dates tied to the product and its key legal events [1]:
- https://www.drugpatentwatch.com/p/stribild/
Sources
[1] DrugPatentWatch.com – Stribild (patent and exclusivity timing): https://www.drugpatentwatch.com/p/stribild/